2025 PCF Challenge Awards: For Metastatic, Lethal Prostate Cancer

The Prostate Cancer Foundation (PCF) is requesting for Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.

Research proposals in the following topic areas are solicited:

• Theranostics.

• Drugging currently undruggable oncology targets: preventing progression to lethal disease.

• Improved biotechnologies for precision medicine.

• First-in-field immunotherapies for prostate cancer.

• Artificial intelligence/machine learning to better inform patient outcomes.

• Host microbiome and tumor metabolism.

Please see eligibility restrictions in the link below. 

Team should include at least 3 researchers (from one institution or more), including one young investigator. 

Funding: $1,000,000 total 

Duration: 2 years 

Research Authority due date: 27.4.25